Diffusion of technologies for the care of older adults with exudative age-related macular degeneration. - Wikidata - wikimedia - TriplyDB

Diffusion of technologies for the care of older adults with exudative age-related macular degeneration.

Diffusion of technologies for the care of older adults with exudative age-related macular degeneration.

http://www.wikidata.org/entity/Q34503375

about

Use of health care claims data to study patients with ophthalmologic conditions Switching to less expensive blindness drug could save medicare part B $18 billion over a ten-year period The effects of technological advances on outcomes for elderly persons with exudative age-related macular degeneration.Bevacizumab and ranibizumab for neovascular age-related macular degeneration: an updated meta-analysis of randomised clinical trials.Diffusion of anti-VEGF injections in the Portuguese National Health System Effect of Prior Anti-VEGF Injections on the Risk of Retained Lens Fragments and Endophthalmitis after Cataract Surgery in the Elderly Introducing Anti-Vascular Endothelial Growth Factor Therapies for AMD Did Not Raise Risk of Myocardial Infarction, Stroke, and Death.Rate of intraoperative complications during cataract surgery following intravitreal injections.

P2860

Q30735544-E13D7558-8930-4B48-8E59-886A40F72CE0 Q34062494-D0F1DAD4-677A-456B-BBFF-7D9B7940ABB7 Q34158108-05EF5F14-BC8B-4604-AAE9-1DABCE253A98 Q34271021-487D3E78-A5F6-4F26-8173-6E0342B3BCD3 Q36329272-90FF0D2F-4F64-4E03-81A5-9052F3B6F574 Q36494723-FFBA0D6C-9EC6-48FB-8538-67DFACC2591F Q39491363-591900CE-F24E-4DD0-9E5E-8947139775D6 Q39733409-59DA4716-FEDC-455A-B867-863A94FD495C

P2860

Diffusion of technologies for the care of older adults with exudative age-related macular degeneration.

http://www.wikidata.org/entity/Q34503375

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Diffusion of technologies for ...... -related macular degeneration.

@ast

Diffusion of technologies for ...... -related macular degeneration.

@en

Diffusion of technologies for ...... -related macular degeneration.

@nl

type

label

Diffusion of technologies for ...... -related macular degeneration.

@ast

Diffusion of technologies for ...... -related macular degeneration.

@en

Diffusion of technologies for ...... -related macular degeneration.

@nl

prefLabel

Diffusion of technologies for ...... -related macular degeneration.

@ast

Diffusion of technologies for ...... -related macular degeneration.

@en

Diffusion of technologies for ...... -related macular degeneration.

@nl

P1433

Q34503375-EB394E59-B39E-4A23-8FB9-5A188FF853A6

P1476

Q34503375-8D1F1590-7E88-46A0-82AF-72BAC790BEEA

P2093

Q34503375-22869D1E-7430-4F70-B8A1-368BA65BB992

Q34503375-26D39BAA-838E-41CE-96FD-27F3FAAD98C5

Q34503375-40F2DEC6-C452-42ED-B967-12A570FEB65E

P2860

Q34503375-19DCDF1C-53E3-4735-B8DB-738745D6B48E

Q34503375-27ACA088-1BBB-4D06-953B-0D0E546C66E8

Q34503375-2CDC0454-A1F9-4037-A438-844B54E5F797

Q34503375-3C5FDD63-89EF-4562-9D37-6535AADEB17E

Q34503375-4AB37637-84C6-4AB0-8DF8-78C2BD7AB75A

Q34503375-4AD6A720-E0ED-4102-9BC5-A3C89A48E0C8

Q34503375-5FB19D9D-4429-4ADE-8130-B57405542F30

Q34503375-6E8E3678-2144-4D63-B345-026B9035D245

Q34503375-81E6AE5E-EB5D-4503-BE2E-1E1EE944E70A

Q34503375-96347323-72E2-432F-801D-9BFF41C2A801

P304

Q34503375-E67BC5E8-8303-4B41-A553-C97684DD4CFD

P31

Q34503375-7E119E4F-506E-4E72-A36C-B4D0FFC1DD49

P356

Q34503375-EED36797-2389-43FF-A407-855630C244AC

P407

Q34503375-33FF1F05-0255-4B73-9960-A0E0EDAD59E2

P433

Q34503375-604633FC-F05C-4403-B6D3-26AD7D252EC3

P478

Q34503375-51246E4C-286D-4328-878F-86C3B428D45F

P50

Q34503375-0CBC872C-58CC-4C69-B165-F8F4B17CBA23

P577

Q34503375-50DA1917-B50D-47EF-930E-DF596C435EB9

P698

Q34503375-A86BA044-B3F9-4012-BFC9-EA51EA57BFA8

P932

Q34503375-79ABCFBB-ADCA-453F-8036-6EAE66B9F319

P356

J.AJO.2012.10.003

P1433

American Journal of Ophthalmology

P1476

Diffusion of technologies for ...... e-related macular degeneration

@en

P2093

Brian W Hanrahan

http://www.w3.org/2001/XMLSchema#string

Frank A Sloan

http://www.w3.org/2001/XMLSchema#string

Grant M Comer

http://www.w3.org/2001/XMLSchema#string

P2860

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study.

Medicare costs for neovascular age-related macular degeneration, 1994-2007.

Intravitreal triamcinolone acetonide for exudative age related macular degeneration.

Determinants of the diffusion of computed tomography and magnetic resonance imaging.

Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

Age-related macular degeneration and blindness due to neovascular maculopathy.

Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseases.

Early clinical experience with ranibizumab for occult and minimally classic neovascular membranes in age-related macular degeneration.

P304

688-96, 696.e1-2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AJO.2012.10.003

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

155

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23219066

http://www.w3.org/2001/XMLSchema#string

P932

3632297

http://www.w3.org/2001/XMLSchema#string